NRC Files 8-K on Financials

Ticker: NRC · Form: 8-K · Filed: Oct 27, 2025 · CIK: 70487

National Research CORP 8-K Filing Summary
FieldDetail
CompanyNational Research CORP (NRC)
Form Type8-K
Filed DateOct 27, 2025
Risk Levellow
Pages2
Reading Time3 min
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, 8-k

TL;DR

NRC dropped its Q3 2025 financials, check the 8-K for the deets.

AI Summary

National Research Corporation (NRC) filed an 8-K on October 27, 2025, reporting on its Results of Operations and Financial Condition. The filing includes financial statements and exhibits related to the period ending October 27, 2025. NRC, incorporated in Delaware, is headquartered in Lincoln, Nebraska.

Why It Matters

This 8-K filing provides investors with updated financial information and operational results for National Research Corporation, crucial for assessing the company's performance and future prospects.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any significant new risks or adverse events.

Key Players & Entities

FAQ

What specific financial information is being reported in this 8-K?

This 8-K reports on the 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.

When was this 8-K filed?

This 8-K was filed on October 27, 2025.

What is the principal executive office address for National Research Corporation?

The principal executive offices are located at 1245 Q Street, Lincoln, Nebraska 68508.

What is the Commission File Number for National Research Corporation?

The Commission File Number for National Research Corporation is 001-35929.

What is the SIC code for National Research Corporation?

The Standard Industrial Classification (SIC) code for National Research Corporation is 8731, which falls under SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH.

Filing Stats: 655 words · 3 min read · ~2 pages · Grade level 12.4 · Accepted 2025-10-27 17:03:13

Filing Documents

02

Item 2.02 Results of Operations and Financial Condition. On October 27, 2025, National Research Corporation, a Delaware corporation (the "Company"), issued a press release announcing its financial and operating results for the third quarter ended September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated by reference herein.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. EXHIBIT NUMBER EXHIBIT DESCRIPTION 99.1 National Research Corporation press release announcing its financial and operating results for the third quarter ended September 30, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). The information contained in Items 2.02 and 9.01 of this report and the exhibits hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The information in Items 2.02 and 9.01 of this report and the exhibits hereto may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act and such statements are subject to the safe harbor created by those sections and the Private Securities Litigation Reform Act of 1995, as amended. Such statements are made based on the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. Actual results or events may differ from those anticipated by forward-looking statements. Please refer to the paragraph at the end of the attached press release and various disclosures by the Company in its press releases, stockholder reports, and filings with the Securities and Exchange Commission for information concerning risks, uncertainties, and other factors that may affect future results. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NATIONAL RESEARCH CORPORATION (Registrant) Date: October 27, 2025 By: /s/ Shane Harrison Shane Harrison Executive Vice Presiden

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing